Prognostic analysis of 669 liver metastasis of colorectal cancer cases
Li Ren,Shi-xu Lv,Yun-Shi Zhong,Jianmin Xu,Ye Wei,Jia Fan,Lun-Xiu Qin,Jian-Hua Wang,Jie-Min Cheng,Sheng Qian,Xinyu Qin
DOI: https://doi.org/10.3760/cma.j.issn.1671-0274.2009.04.004
2009-01-01
Abstract:Objective To evaluate the relation between different therapy and survival rate of liver metastasis of eoloreetal cancer (LMCC). Methods Clinical data of 669 LMCC patients, collected from Fudan University Zliongshan Hospital from January 2000 to July 2008, were analyzed retrospectively.Results Of the 669 eases, 379 eases were synchronous liver metastases (SLM) and 290 cases were metachronous liver metastases (MLM). There were no significant differeneos in age, gender and position of primary tumor between SLM and MLM groups (P>0.05), but as to liver metastasis charaeteristics (liver lobe involved, focus number and maximal focus diameter) and CEA, CA19-9 before therapy,there were significant differences (P<0.05). Two hundred and fifty-three eases underwent curative hepatic resection, including 123 cases in SLM and 130 eases in MLM. Until October 31, 2008, all the cases were followedup. The median survival time of SLM was (11 ± 1) months and of MLM (23+2) months (P<0.01). Five-year survival rate of SLM was 6.4% and of MLM 11.4%(P<0.01). As to different treatments, median survival time and 5-year survival rate of curative hepatic resection group were 37months and 35.6%, and of non-operation groups (i.e. intervention, chemotherapy, radiofrequeney therapy and percutaneous ethanol injection) were 5 to 26 months and 0 to 3.6% respectively (P<0.05).Conclusions Curative hepatic resection is the first choice of liver metastasis of colorectal cancer,which can improve the survival rate. Resection rate and survival of MLM are better than those of SLM.
Key words: Colorectal neoplasms; Neoplasm metastasis, liver; Hepatectomy; Prognosis